Quarterly report pursuant to Section 13 or 15(d)

Consolidated Interim Consolidated Statements of Operations and Comprehensive loss (Unaudited)

v3.19.1
Consolidated Interim Consolidated Statements of Operations and Comprehensive loss (Unaudited) - USD ($)
3 Months Ended
Feb. 28, 2019
Feb. 28, 2018
SALES $ 11,107 $ 28,116
COST OF SALES (5,549) (20,741)
GROSS PROFIT 5,558 7,375
EXPENSES:    
Depreciation 9,178 3,353
Amortization of patent rights 1,833  
Foreign currency translation loss 13,533 8,027
Selling, general and administration 1,097,968 290,443
TOTAL OPERATING EXPENSES 1,122,512 301,823
LOSS FROM OPERATIONS (1,116,954) (294,448)
Accretion (102,858) (28,748)
Change in fair value of derivative liabilities 395,430 1,391
Other expense-interest (59,390) (33,907)
LOSS BEFORE INCOME TAXES (883,772) (355,712)
Income taxes 0 0
NET LOSS (883,772) (355,712)
Foreign exchange translation adjustment for the period (3,740) (574)
COMPREHENSIVE LOSS $ (887,512) $ (356,286)
Loss per share - basic and diluted (in dollars per share) $ (0.009) $ (0.004)
Weighted average common shares outstanding during the period (in shares) 102,435,923 93,014,134